Submission Our submission services include a wide variety meeting the global regulatory standards and requirements. Orphan Designations Paediatric Investigation Plans (PIPs) Centralised Decentralised Clinical Trial or Investigational New Drug Applications – CTA/IND Invitro/CDX Marketing Authorisation or New Drug Applications – MAA/(s)NDA/(s)BLA/ANDA Biosimilar Submissions EU Centralised, Decentralised, Mutual Recognition Procedures EU CHMP, PRAC and CMD(h) Referrals EU Small, Medium Enterprise (SME) Status Scientific Advice or Pre-Phase III Health Authority Interactions Label/Safety Updates Marketing Authorisation/License Renewals
